Effect of trans arterial infusion therapy to hepatocelluar carcinoma

Effect of trans arterial infusion therapy to hepatocelluar carcinoma with massive vessel invasion - EOTAITTHCWMVI

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041180127

Enrollment

Registered

2019-03-26

Start date

2014-12-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

performannce status 0,1

Interventions

carboplatin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: resectable, Child-Pugh score A, performannce status 0,1

Exclusion criteria

Exclusion criteria: extrahepatic metastasis

Design outcomes

Primary

Measure	Time frame
Desease free survival	—

Secondary

Measure	Time frame
Over all survival,respons rate	—

Contacts

Public Contactyoshinao tanahashi

Fujita Healthy University Hospital

yoshinao@fujita-hu.ac.jp+81-562-93-9254

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026